ARIPIPRAZOLE and ANXIETY

Overview

ANXIETY is the #5 most commonly reported adverse reaction for ARIPIPRAZOLE, manufactured by Otsuka America Pharmaceutical, Inc.. There are 4,991 FDA adverse event reports linking ARIPIPRAZOLE to ANXIETY. This represents approximately 2.4% of all 209,896 adverse event reports for this drug.

Patients taking ARIPIPRAZOLE who experience anxiety should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

ANXIETY is a less commonly reported adverse event for ARIPIPRAZOLE, but still significant enough to appear in the safety profile.

Other Side Effects of ARIPIPRAZOLE

In addition to anxiety, the following adverse reactions have been reported for ARIPIPRAZOLE:

• DRUG INEFFECTIVE — 8,139 reports
• WEIGHT INCREASED — 7,698 reports
• OFF LABEL USE — 7,392 reports
• PRODUCT USE IN UNAPPROVED INDICATION — 5,248 reports
• FATIGUE — 4,187 reports
• SUICIDAL IDEATION — 3,991 reports
• DEPRESSION — 3,950 reports
• NAUSEA — 3,904 reports
• INSOMNIA — 3,817 reports
• TREMOR — 3,610 reports

Other Drugs Associated with ANXIETY

The following drugs have also been linked to anxiety in FDA adverse event reports:

Does ARIPIPRAZOLE cause ANXIETY?

ANXIETY has been reported as an adverse event in 4,991 FDA reports for ARIPIPRAZOLE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is ANXIETY with ARIPIPRAZOLE?

ANXIETY accounts for approximately 2.4% of all adverse event reports for ARIPIPRAZOLE, making it a notable side effect.

What should I do if I experience ANXIETY while taking ARIPIPRAZOLE?

If you experience anxiety while taking ARIPIPRAZOLE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages